CN Patent

CN106432209A — Lumacaftor的新晶型及其制备方法

Assigned to Crystal Pharmatech Co Ltd · Expires 2017-02-22 · 9y expired

What this patent protects

本发明提供lumacaftor的晶型A及其制备方法。本发明提供的晶型A的X射线粉末衍射图在2theta值为8.8°±0.2°、21.2°±0.2°、22.2°±0.2°处具有特征峰。本发明的晶型A稳定性好，比之现有技术溶解度更高，对未来该药物的优化和开发具有重要价值。

USPTO Abstract

本发明提供lumacaftor的晶型A及其制备方法。本发明提供的晶型A的X射线粉末衍射图在2theta值为8.8°±0.2°、21.2°±0.2°、22.2°±0.2°处具有特征峰。本发明的晶型A稳定性好，比之现有技术溶解度更高，对未来该药物的优化和开发具有重要价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN106432209A
Jurisdiction
CN
Classification
—
Expires
2017-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Crystal Pharmatech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.